Alcon's statement regarding whistleblower allegations out of China

Alcon Laboratories Inc. (Alcon) was made aware of allegations of potential misconduct in China. Alcon does not tolerate activities that are not in compliance with the laws and regulations in the markets where we operate. Upon learning of any allegations, the Company launches an internal investigation. When any inappropriate activities are identified, we take swift remedial action.
Alcon is committed to upholding high standards of ethical business conduct and to operate compliantly in all aspects of its work around the world, including in China. All Alcon employees are expected to adhere to the Company's Code of Conduct of ethical business behavior.
Alcon's Patient Experience Surveys are designed to provide valuable feedback and are conducted by a reputable and experienced independent third party with expertise in survey design, electronic data capture, statistical analysis and program management. In an effort to ensure compliance, Alcon China conducted an internal review of the program that was in place in 2012 and found that we acted in accordance with the appropriate rules, regulations and internal SOPs.